Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), bought 27,000 shares at $3.58 ($97K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AKBA | SELL | 2025-02-04 | $163K | — | Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |